Martin Mackay - 02 Jan 2025 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
02 Jan 2025
Net transactions value
+$65,000
Form type
4
Filing time
06 Jan 2025, 17:07:32 UTC
Previous filing
30 Jul 2024
Next filing
15 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $65,000 +92,857 $0.7000 92,857 02 Jan 2025 Common Stock 92,857 $0.9500 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025.
F2 This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $65,000.